Jury awards $4.5 million in Vioxx verdict against Merck
ATLANTIC CITY, New Jersey   - A jury on Wednesday found Merck & Co. failed to warn Vioxx users of the drug's heart risks and ordered it to pay a 77-year-old plaintiff at least $4.5 million in a decision that raises questions about the company's future defense of thousands of lawsuits filed over the medicine.
      
       
